--------------------------
OMB APPROVAL
--------------------------
OMB Number: 3235-0518
Expires: March 31, 2005
Estimated average burden
hours per response....0.13
--------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM CB
TENDER OFFER/RIGHTS OFFERING NOTIFICATION FORM
(AMENDMENT NO. 2)
Please place an X in the box(es) to designate the appropriate rule provision(s)
relied upon to file this Form:
Securities Act Rule 801 (Rights Offering) [ ]
Securities Act Rule 802 (Exchange Offer) [X]
Exchange Act Rule 13c-4(h)(8) (Issuer Tender Offer) [ ]
Exchange Act Rule 14d-1(c) (Third Party Tender Offer) [X]
Exchange Act Rule 14c-2(d) (Subject Company Response) [ ]
Filed or submitted in paper if permitted by Regulation S-T Rule 101(b)(8) [ ]
Note: Regulation S-T Rule 101(b)(8) only permits the filing or submission of a
Form CB in paper by a party that is not subject to the reporting requirements of
Section 13 or 15(d) of the Exchange Act.
Drew Scientific Group PLC
--------------------------------------------------------------------
(Name of Subject Company)
N/A
--------------------------------------------------------------------
(Translation of Subject Company's Name into English (if applicable))
United Kingdom
--------------------------------------------------------------------
(Jurisdiction of Subject Company's Incorporation or Organization)
Escalon Medical Corp.
--------------------------------------------------------------------
(Name of Person(s) Furnishing Form)
Ordinary Shares of Drew Scientific Group PLC
--------------------------------------------------------------------
(Title of Class of Subject Securities)
Not applicable
--------------------------------------------------------------------
(CUSIP Number of Class of Securities (if applicable))
c/o Richard J. DePiano, Chairman and CEO, Escalon Medical Corp.,
575 East Swedesford Road, Suite
--------------------------------------------------------------------------------
100, Wayne, Pennsylvania 19087; telephone: (610) 688-6830
(As offeror in the tender offer)
--------------------------------------------------------------------------------
(Name, Address (including zip code) and Telephone Number (including area
code) of Person(s) Authorized to Receive Notices and Communications on
Behalf of Subject Company)
Commencement of exchange offer in the U.K. on 5/14/04
-----------------------------------------------------
(Date Tender Offer/Rights Offering Commenced)
PART I - INFORMATION SENT TO SECURITY HOLDERS
ITEM 1. HOME JURISDICTION DOCUMENTS
Exhibit 1 Press Release - Offer by Escalon Medical Corp. for all
the Outstanding Share Capital of Drew Scientific Group
PLC dated June 29, 2004. Revision of Offer, Extension
and Level of Acceptances
ITEM 2. INFORMATIONAL LEGENDS
Not applicable.
PART II - INFORMATION NOT REQUIRED TO BE SENT TO SECURITY HOLDERS
(1) Not applicable.
(2) No documents are incorporated by reference in the Home Jurisdiction
Document.
PART III - CONSENT TO SERVICE OF PROCESS
Not applicable.
2
PART IV - SIGNATURES
After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
/s/ Richard J. DePiano
-----------------------------------------------------------
(Signature)
Richard J. DePiano, Chairman and CEO, Escalon Medical Corp.
-----------------------------------------------------------
(Name and Title)
June 29, 2004
-----------------------------------------------------------
(Date)
3